Versant Venture Capital VI, L.P. - 10%+ Owner at Monte Rosa Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
GLUE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Versant Venture Capital VI, L.P. since 12 Mar 2025

Holdings reported by Versant Venture Capital VI, L.P. for Monte Rosa Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4,079,469 $38,386,987 $9.41 28 Oct 2024 Direct
Common Stock 1,573,453 $14,805,878 $9.41 29 Oct 2024 Indirect

Transactions reported by Versant Venture Capital VI, L.P. for Monte Rosa Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.